The endocannabinoidome–gut microbiome–brain axis as a novel therapeutic target for autism spectrum disorder
Abstract Introduction: Autism spectrum disorder (ASD) is characterized by disruption of the gut–brain axis, which leads to behavioral, psychiatric, metabolic…